| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.94▼ | 1.94▼ | 1.97▼ | 2.00▼ | 2.04▼ |
| MA10 | 1.95▼ | 1.97▼ | 1.99▼ | 1.99▼ | 2.01▼ |
| MA20 | 1.98▼ | 2.00▼ | 2.01▼ | 2.07▼ | 2.13▼ |
| MA50 | 2.01▼ | 1.99▼ | 1.99▼ | 2.00▼ | 3.30▼ |
| MA100 | 2.01▼ | 1.98▼ | 2.05▼ | 2.18▼ | 3.65▼ |
| MA200 | 1.99▼ | 2.07▼ | 2.04▼ | 3.21▼ | 4.52▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.006▼ | -0.011▼ | -0.012▼ | -0.012▼ | 0.067▲ |
| RSI | 34.589▼ | 38.320▼ | 38.945▼ | 45.500▼ | 36.810▼ |
| STOCH | 9.091▼ | 9.091▼ | 29.545 | 36.208 | 62.048 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -80.851▼ | -50.000 |
| CCI | -99.738 | -104.762▼ | -166.559▼ | -57.008 | -1.115 |
|
Saturday, October 20, 2018 04:44 AM
LEXINGTON, Mass., Oct. 20, 2018 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies, cancer vaccines, and adoptive cell therapies 2, ...
|
|
Sunday, October 14, 2018 10:21 AM
Agenus Inc (NASDAQ: AGEN) – Phase 1/2 data for AGEN2034 and AGEN1884 (solid tumors) & Phase 1/2 data for AGEN2034 (cervical cancer)Oncomed Pharmaceuticals Inc (NASDAQ: OMED) – Phase 1b data (Navicixiz...
|
|
Thursday, October 11, 2018 06:44 AM
Agenus (AGEN) has completed the sale of 18,459 unregistered shares of Series C-1 Convertible Preferred Stock at $2,167 per share to institutional investors. Net proceeds were ~$39.9M. Shares are ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/10/18 | 2.00 | 2.06 | 1.92 | 1.96 | 1,148,386 |
| 18/10/18 | 2.02 | 2.07 | 1.98 | 2.00 | 728,346 |
| 17/10/18 | 1.98 | 2.07 | 1.93 | 2.06 | 749,055 |
| 16/10/18 | 2.00 | 2.01 | 1.90 | 1.98 | 1,723,245 |
| 15/10/18 | 1.95 | 2.02 | 1.90 | 1.98 | 800,173 |
| 12/10/18 | 2.05 | 2.07 | 1.92 | 1.95 | 736,857 |
| 11/10/18 | 1.90 | 2.09 | 1.87 | 2.00 | 1,638,081 |
| 10/10/18 | 1.97 | 2.03 | 1.90 | 1.92 | 1,192,080 |
| 09/10/18 | 2.03 | 2.09 | 1.95 | 1.97 | 1,343,538 |
| 08/10/18 | 2.12 | 2.138 | 2.00 | 2.06 | 861,296 |
|
|
||||
|
|
||||
|
|
||||
|
|